Taxol (paclitaxel) was approved by FDA for the treatment of patients with recurrent ovarian cancer.
Menzin
A W
AW
King
S A
SA
Aikins
J K
JK
Mikuta
J J
JJ
Rubin
S C
SC
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000556:secondary; D000368:Aged; D005260:Female; D006801:Humans; D017239:Paclitaxel / Q000627:therapeutic use*; D016879:Salvage Therapy; D012878:Skin Neoplasms / Q000188:drug therapy / Q000556:secondary*; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*
D017239:Paclitaxel